NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

NORRIS MEDICINES

BSE: 524414 21 Feb 2025
Services
₹ 20.5
Norris Medicines Ltd. specializes in Trading & Distributors within the Services sector.

NORRIS MEDICINES - Share Price & Details

Market Cap
₹20.5
High /Low
27.7 / 10.7
Stock P/E
NA
Book Value
₹-14.4
Dividend Yield
0.0
ROCE
-8.43
ROE
₹NA
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹234.0
Debt
21.6
CMP / FCF
171.0
Debt to equity
₹NA
NP Ann
-1.19
High price all time
36.8
Piotroski score
₹6.0
Graham Number
NA
No. Eq. Shares
1.0
Net CF
₹0.02
Net profit
-0.84
Price to book value
NA
Interest Coverage
₹-0.9
Low price all time
2.45
Industry PE
29.9
Reserves
₹-24.3
Free Cash Flow
₹0.26

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Alna Trading & Exports Ltd.,NA-0.81
Oseaspre Consultants Ltd.,NA-1.92
NORRIS MEDICINES LTD.11.06-0.28
Cargosol Logistics LimitedNANA
Globe Commercials Limited426.891.523.86

Peer Comparison Chart


About NORRIS MEDICINES

Norris Medicines Ltd., with Security Code 524414, is a leading player in the Trading & Distributors industry, categorized under the Services sector, offering Equity instruments.


Latest News

Q2 Results Today: Hero MotoCorp, Lemon Tree Hotels, HAL, Glenmark Pharma among 1181 companies to post earnings on Nov 14 | Company Business News

(21 Nov 2024)
In a highly anticipated day for earnings announcements, major players, including Hero MotoCorp, Lemon Tree Hotels, Hindustan Aeronautics Ltd...
Read more →

Norris Medicines' Stock Reaches 52-Week High, Outperforms Sector with Impressive 70.37% Gain

(15 Nov 2024)
Norris Medicines, a microcap pharmaceutical company, has been making headlines in the stock market as its stock price reached a 52-week high on November 14,...
Read more →

Norris Medicines reports standalone net loss of Rs 0.36 crore in the September 2024 quarter

(14 Nov 2024)
Net Loss of Norris Medicines reported to Rs 0.36 crore in the quarter ended September 2024 as against net loss of Rs 0.48 crore during the previous quarter...
Read more →

India discovers more toxic cough syrups, months after some produced in the country were linked to the deaths of 141 children worldwide

(12 Nov 2024)
India's drug regulator has found cough syrup and allergy syrup made by Norris Medicines ( NORI.BO ) to be toxic, according to a government report.
Read more →

Norris Medicine Standalone June 2024 Net Sales at Rs 0.72 crore, down 23.4% Y-o-Y

(19 Aug 2024)
Quarterly Net Loss at Rs. 0.37 crore in June 2024 up 40.45% from Rs. 0.61 crore in June 2023. EBITDA stands negative at Rs. 0.15 crore in...
Read more →

Norris Medicines reports standalone net loss of Rs 0.37 crore in the June 2024 quarter

(16 Aug 2024)
Net Loss of Norris Medicines reported to Rs 0.37 crore in the quarter ended June 2024 as against net loss of Rs 0.61 crore during the previous quarter ended...
Read more →